Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric B Suhler

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
The Journal of Rheumatology|September 3, 2010
The dilemma of central serous retinopathy, a corticosteroid-induced complication, in patients with ocular inflammatory diseaseSeema R Gupta, Eric B Suhler, James T Rosenbaum
Cutaneous and Ocular Toxicology|December 2, 2009
Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reportsFrederick W Fraunfelder, Eric B Suhler, Frederick T Fraunfelder
Ocular Immunology and Inflammation|February 14, 2012
Drug-induced inflammation in patients on TNFα inhibitorsEmmett T Cunningham, Sirichai Pasadhika, Eric B Suhler, et al.
Ocular Immunology and Inflammation|October 2, 2019
Inferior Corneal Haze and Inflammatory Endotheliopathy Related to Pars PlanitisAkshay S Thomas, Amro Ali, Sruthi Arepalli, et al.
International Ophthalmology Clinics|March 3, 2015
Drug-induced uveitisAmde Selassie Shifera, Laura Kopplin, Phoebe Lin, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 1, 2002
Symmetric peripheral iris depigmentation in vogt-koyanagi-harada syndromeEric B Suhler, Ronald R Buggage, Robert B Nussenblatt, et al.
Ocular Immunology and Inflammation|November 15, 2022
Rituximab for Ocular Inflammatory DiseaseEmmett T Cunningham, Caleb Ng, Eric B Suhler, et al.
International Ophthalmology Clinics|March 3, 2015
Biological response modifiers in the treatment of noninfectious uveitisLaura J Kopplin, Amde S Shifera, Eric B Suhler, et al.
Journal of Clinical & Experimental Ophthalmology|January 26, 2016
Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye DiseaseErick Rivera-Grana, Phoebe Lin, Eric B Suhler, et al.
Expert Opinion on Pharmacotherapy|February 22, 2013
Pharmacotherapy of scleritis: current paradigms and future directionsRobert M Beardsley, Eric B Suhler, James T Rosenbaum, et al.
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Rheumatology|September 3, 2010
The dilemma of central serous retinopathy, a corticosteroid-induced complication, in patients with ocular inflammatory diseaseSeema R Gupta, Eric B Suhler, James T Rosenbaum
Cutaneous and Ocular Toxicology|December 2, 2009
Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reportsFrederick W Fraunfelder, Eric B Suhler, Frederick T Fraunfelder
Ocular Immunology and Inflammation|February 14, 2012
Drug-induced inflammation in patients on TNFα inhibitorsEmmett T Cunningham, Sirichai Pasadhika, Eric B Suhler, et al.
Ocular Immunology and Inflammation|October 2, 2019
Inferior Corneal Haze and Inflammatory Endotheliopathy Related to Pars PlanitisAkshay S Thomas, Amro Ali, Sruthi Arepalli, et al.
International Ophthalmology Clinics|March 3, 2015
Drug-induced uveitisAmde Selassie Shifera, Laura Kopplin, Phoebe Lin, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 1, 2002
Symmetric peripheral iris depigmentation in vogt-koyanagi-harada syndromeEric B Suhler, Ronald R Buggage, Robert B Nussenblatt, et al.
Ocular Immunology and Inflammation|November 15, 2022
Rituximab for Ocular Inflammatory DiseaseEmmett T Cunningham, Caleb Ng, Eric B Suhler, et al.
International Ophthalmology Clinics|March 3, 2015
Biological response modifiers in the treatment of noninfectious uveitisLaura J Kopplin, Amde S Shifera, Eric B Suhler, et al.
Journal of Clinical & Experimental Ophthalmology|January 26, 2016
Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye DiseaseErick Rivera-Grana, Phoebe Lin, Eric B Suhler, et al.
Expert Opinion on Pharmacotherapy|February 22, 2013
Pharmacotherapy of scleritis: current paradigms and future directionsRobert M Beardsley, Eric B Suhler, James T Rosenbaum, et al.
Pageof 14